WeTrade Showcases Global Strength at the 8th Zhengzhou Finance Expo

WeTrade boosted its reputation at the 8th Zhengzhou Finance Expo on 18 April 2026, reinforcing its position as a globally trusted broker. 

 

At the event, WeTrade stood out with its mature global footprint and integrated product ecosystem, quickly becoming one of the most prominent names at the expo. 

 

 

The event brought together leading global institutions to explore shifting market structures, evolving asset allocation strategies, and the growing impact of financial technology. WeTrade was invited to share insights on building sector frameworks. 

 

 

A Standout Presence 

 

As an official partner of Paris Saint-Germain, WeTrade’s booth drew significant attention throughout the event. From start to finish, visitors engaged in discussions on global market opportunities, trading strategies, and platform capabilities. 

 

This strong turnout underscored market confidence in WeTrade’s expertise and brand strength. Through live product demonstrations and strategic insights, WeTrade reinforced its position as an industry benchmark. 

 

 

Industry Recognition 

 

At the official awards ceremony, WeTrade was named “Broker of the Year”, recognising its consistent performance, robust risk management framework, and client-focused approach. 

 

The award highlights both industry endorsement and the long-standing trust of its global client base. 

 

 

Expanding Global Reach 

 

WeTrade’s presence at the expo demonstrates its continued commitment to strengthening global connectivity. 

 

 

As China’s role in the global financial system grows, WeTrade is enhancing its ability to connect markets, optimise global resource allocation, and support cross-border investment flows. 

 

WeTrade will continue to build on its technology-driven strategy and client-first approach, further expanding its ecosystem to serve global communities.  

Risk warning:Forex and CFD products have market risks, and leverage products may not be suitable for all clients.Please read our risk statement